Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 98
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Mol Pharm ; 17(7): 2319-2328, 2020 07 06.
Article in English | MEDLINE | ID: mdl-32501703

ABSTRACT

Preclinical evaluation of modern oral dosage forms requires more advanced in vitro devices as the trend of selecting low solubility, high permeability compounds for commercial development continues. Current dissolution methodologies may not always be suitable for such compounds due to excessive fluid volume, high fluid shear rates, heterogeneity of shear rates, suboptimal fluid flow, and, ultimately, the lack of absorption ability (Gray The Science of USP 1 and 2 Dissolution: Present Challenges and Future Relevance; Pharmaceutical Research, 2009; Vol. 26; pp 1289-1302). Herein, a new dissolution apparatus is introduced in combination with an ultrathin, semipermeable polymer membrane that mimics human passive absorption for lipophilic compounds. The ultrathin large-area polydimethylsiloxane (PDMS) membrane (UTLAM) absorption system is designed to mimic the dissolution and passive transcellular diffusion process representing the oral absorption pathway. A simple spin-casting method was developed to fabricate the ultrathin highly uniform membranes. To minimize membrane resistance to diffusion and maximize transport across the polymer membrane, 10-40 µm PDMS membranes were successfully prepared. A new diffusion cell was designed and tested to support the UTLAM and incorporates a hydrofoil impeller for more desirable hydrodynamics and mixing, using ibuprofen as a model weak acidic drug. UTLAM permeability was sufficiently high that the aqueous boundary layer contributed to the overall permeability of the system. This diffusion cell system demonstrated that, when the aqueous diffusion layer contributes to the overall resistance to transport, the pH at which absorption is 50% of maximum (pH50%) shifts from the pKa to higher values, demonstrating why weak acid drugs can exhibit high absorption at pH's significantly greater than their pKa. High rates of transport across the UTLAM are possible for drugs with high partition coefficients (i.e., BCS II compounds even under mostly ionized conditions), and PDMS UTLAMs may be tailored to simulate human intestinal passive absorption rates.


Subject(s)
Dimethylpolysiloxanes/chemistry , Drug Liberation , Hydrodynamics , Ibuprofen/pharmacokinetics , Membranes, Artificial , Models, Biological , Administration, Oral , Computer Simulation , Diffusion , Humans , Hydrogen-Ion Concentration , Intestinal Absorption , Permeability , Solubility , Solutions/pharmacokinetics
2.
Kidney Blood Press Res ; 44(2): 264-276, 2019.
Article in English | MEDLINE | ID: mdl-30955008

ABSTRACT

BACKGROUND/AIMS: Studies on the long-term clinical benefits of hemodiafiltration (HDF) and high-flux hemodialysis (HFHD) are very limited. This study aimed to investigate the hospitalization rate and aortic arch calcification (AAC) of these two dialysis modalities over 6 years. METHODS: Participants who received regular HDF and HFHD in one hospital-facilitated hemodialysis center were prospectively enrolled after matching for age, sex, and diabetes between January 2009 and December 2014. Medical records were reviewed retrospectively on demographics, laboratory variables, calcified scores in aortic arch measured by chest radiography, and rates of hospital admission. Cox proportional hazard regression and linear regression were used to obtain the outcome results. RESULTS: The HDF and HFHD groups consisted of 108 and 102 participants, respectively. Levels of laboratory variables including small soluble solutes and Kt/V were not statistically different over the 6-year period between the HDF and HFHD groups. Calcified scores of the aortic arch increased over 6 years in both groups. The changes in the mean calcified scores were significant when compared between the two groups (0.44-1.82 in HFHD, 0.79-1.8 in HDF, respectively, p = 0.008). Hospitalization rates were 735 per 1,000 patients in the HDF group and 852 per 1,000 patients in the HFHD group, respectively. No significant difference was observed in frequency and days of hospitalization between HDF and HFHD. CONCLUSION: Hospitalization rates and AAC were observed to be equal for HDF and HFHD.


Subject(s)
Aortic Valve Stenosis , Hemodiafiltration/standards , Hospitalization , Renal Dialysis/standards , Solutions/pharmacokinetics , Adult , Aged , Aorta, Thoracic/pathology , Calcinosis , Female , Hemodiafiltration/methods , Humans , Male , Middle Aged , Renal Dialysis/methods , Retrospective Studies
3.
Br J Clin Pharmacol ; 82(5): 1315-1324, 2016 11.
Article in English | MEDLINE | ID: mdl-27378314

ABSTRACT

AIMS: The aim of the present study was to investigate the safety, tolerability, dose proportionality and relative bioavailability of tablet and oral solution formulations of BI 409306 in healthy male subjects, and to compare the safety and pharmacokinetics in subjects who were extensive metabolizers (EMs) or poor metabolizers (PMs) of cytochrome P450 (CYP)-2C19. METHODS: The present randomized, double-blind, placebo-controlled, single-centre study evaluated single rising doses of BI 409306 (0.5-500 mg) administered as a tablet or oral solution to EMs or PMs. RESULTS: Of 80 enrolled subjects (mean age 36.7 years), 79 (CYP2C19 EMs, 71; CYP2C19 PMs, eight) received treatment and completed the study. Adverse events (AEs) were mild to moderate in intensity. Overall, 17/71 (23.9%) EMs and 6/8 (75.0%) PMs experienced 28 and eight AEs, respectively, of which, 25 and seven AEs, respectively, were considered to be drug related. The most frequently reported AEs were nervous system and eye disorders; all occurred shortly (20-30 min) after administration and mostly resolved within 1-2 h. No serious AEs occurred. BI 409306 systemic absorption and elimination were rapid; peak plasma concentration (Cmax ) was reached <1 h after drug administration, and the half-life ranged from 0.99 h to 2.71 h. Both the tablet and oral solution resulted in similar exposures. In PMs, at dose levels of 10 mg and 100 mg, Cmax was 2.2-2.3-fold higher, and the area under the plasma concentration-time curve over the time interval 0 extrapolated to infinity was 4.1-5.0-fold higher compared with EMs. CONCLUSIONS: In healthy male subjects, BI 409306 was generally safe and well tolerated, with rapid absorption and elimination. Systemic exposure was higher in CYP2C19 PMs than EMs at the same dose level.


Subject(s)
3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , Administration, Oral , Adult , Biological Availability , Cytochrome P-450 CYP2C19/genetics , Dose-Response Relationship, Drug , Double-Blind Method , Humans , Male , Middle Aged , Phosphodiesterase Inhibitors/administration & dosage , Phosphodiesterase Inhibitors/adverse effects , Phosphodiesterase Inhibitors/pharmacokinetics , Solutions/administration & dosage , Solutions/adverse effects , Solutions/pharmacokinetics , Tablets/administration & dosage , Tablets/adverse effects , Tablets/pharmacokinetics , Young Adult
4.
Eur J Anaesthesiol ; 33(7): 475-82, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27058509

ABSTRACT

An understanding of the half-life (T1/2) of infused fluids can help prevent iatrogenic problems such as volume overload and postoperative interstitial oedema. Simulations show that a prolongation of the T1/2 for crystalloid fluid increases the plasma volume and promotes accumulation of fluid in the interstitial fluid space. The T1/2 for crystalloids is usually 20 to 40 min in conscious humans but might extend to 80 min or longer in the presence of preoperative stress, dehydration, blood loss of <1 l or pregnancy.The longest T1/2 measured amounts to between 3 and 8 h and occurs during surgery and general anaesthesia with mechanical ventilation. This situation lasts as long as the anaesthesia. The mechanisms for the long T1/2 are only partly understood, but involve adrenergic receptors and increased renin and aldosterone release. In contrast, the T1/2 during the postoperative period is usually short, about 15 to 20 min, at least in response to new fluid.The commonly used colloid fluids have an intravascular persistence T1/2 of 2 to 3 h, which is shortened by inflammation. The fact that the elimination T1/2 of the infused macromolecules is 2 to 6 times longer shows that they also reside outside the bloodstream. With a colloid, fluid volume is eliminated in line with its intravascular persistence, but there is insufficient data to know if this is the same in the clinical setting.


Subject(s)
Fluid Therapy , Anesthesia , Crystalloid Solutions , Fluid Therapy/adverse effects , Half-Life , Humans , Infusions, Intravenous , Isotonic Solutions , Plasma Substitutes , Respiration, Artificial , Solutions/administration & dosage , Solutions/pharmacokinetics
5.
J Pharmacokinet Pharmacodyn ; 42(2): 151-61, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25678215

ABSTRACT

The current study aims to provide the closed form solutions of one-compartment open models exhibiting simultaneous linear and nonlinear Michaelis-Menten elimination kinetics for single- and multiple-dose intravenous bolus administrations. It can be shown that the elimination half-time ([Formula: see text]) has a dose-dependent property and is upper-bounded by [Formula: see text] of the first-order elimination model. We further analytically distinguish the dominant role of different elimination pathways in terms of model parameters. Moreover, for the case of multiple-dose intravenous bolus administration, the existence and local stability of the periodic solution at steady state are established. The closed form solutions of the models are obtained through a newly introduced function motivated by the Lambert W function.


Subject(s)
Pharmaceutical Preparations/metabolism , Solutions/pharmacokinetics , Injections, Intravenous/methods , Kinetics , Models, Biological
6.
Analyst ; 139(5): 870-81, 2014 Mar 07.
Article in English | MEDLINE | ID: mdl-24350328

ABSTRACT

Given the importance of nanoparticle surface composition in nanotoxicology, analytical tools that can probe nanoparticle surfaces in aqueous media are crucial but remain limited. Attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy is a technique capable of in situ characterization of the liquid-solid interface to probe surface adsorption on nanoparticle surfaces in environmentally and biologically relevant media. Furthermore, given that the interfacial region in these media is dynamic, ATR-FTIR spectroscopy facilitates monitoring these dynamics by interrogating a layer of immobilized nanoparticles coated on the ATR element while changing the overlying aqueous phase. The molecular information acquired from this technique allows for the determination of the adsorption mode, including conformational and structural changes of the coordinating ligand, and can directly measure ligand displacement reactions. Furthermore, in some cases, ATR-FTIR spectroscopy can be used as a quantitative surface analytical tool. In this article, we briefly review the fundamentals of the technique and then provide several examples of using ATR-FTIR spectroscopy to probe nanoparticle surfaces in general with respect to: (i) the adsorption of different environmentally and biologically relevant coordinating ligands; (ii) competitive ligand adsorption and; (iii) the determination of kinetic and thermodynamic parameters. We have also investigated surface adsorption of TiO2 nanoparticles in different biological media typically used for toxicity studies and show that the surface composition of TiO2 nanoparticles depends to a large extent on the composition of the medium due to surface adsorption. This result has important implications for the interpretation of toxicity data as well as inter-comparisons between toxicity studies.


Subject(s)
Green Chemistry Technology/methods , Nanoparticles/chemistry , Spectroscopy, Fourier Transform Infrared/methods , Adsorption , Nanoparticles/metabolism , Solutions/chemistry , Solutions/pharmacokinetics
7.
AAPS PharmSciTech ; 15(1): 96-102, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24151144

ABSTRACT

The aim of this investigation was to examine the efficacy of PhytoSolve and Phosal-based formulation (PBF) to enhance the oral bioavailability of mebudipine, which is a poorly water-soluble calcium channel blocker. The solubility of mebudipine in various oils was determined. PhytoSolve was prepared with a medium-chain triglyceride (MCT) oil (20%), soybean phospholipids (5%), and a 70% fructose solution (75%). The influence of the weight ratio of Phosal 50PG to glycerol in PBF on the mean globule size was studied with dynamic light scattering. The optimized formulation was evaluated for robustness toward dilution, transparency, droplet size, and zeta potential. The in vivo oral absorption of different mebudipine formulations (PhytoSolve, PBF, oily solution, and suspension) were evaluated in rats. The optimized PBF contained Phosal 50PG/glycerol in a 6:4 ratio (w/w). The PBF and PhytoSolve formulations were miscible with water in any ratio and did not demonstrate any phase separation or drug precipitation over 1 month of storage. The mean particle size of PhytoSolve and PBF were 138.5 ± 9.0 and 74.4 ± 2.5 nm, respectively. The in vivo study demonstrated that the oral bioavailability of PhytoSolve and PBF in rats was significantly higher than that of the other formulations. The PhytoSolve and PBF formulations of mebudipine are found to be more bioavailable compared with suspension and oily solutions during an in vivo study in rats. These formulations might be new alternative carriers that increase the oral bioavailability of poorly water-soluble molecules, such as mebudipine.


Subject(s)
Nifedipine/analogs & derivatives , Absorption , Administration, Oral , Animals , Biological Availability , Chemistry, Pharmaceutical/methods , Fructose/chemistry , Male , Nifedipine/chemistry , Nifedipine/pharmacokinetics , Oils/chemistry , Particle Size , Phospholipids/chemistry , Rats , Rats, Wistar , Solubility , Solutions/chemistry , Solutions/pharmacokinetics , Suspensions/chemistry , Suspensions/pharmacokinetics , Triglycerides/chemistry
8.
Anal Chem ; 84(24): 10671-8, 2012 Dec 18.
Article in English | MEDLINE | ID: mdl-23106346

ABSTRACT

A dissolution model that integrates the solid-liquid interface kinetics and the mass transport kinetics is introduced. Such a model reduces to the Noyes-Whitney equation under special conditions, but offers expanded range of applicability and flexibility fitting dissolution profiles when interfacial kinetics and interfacial concentration deviate from the assumptions implied in the Noyes-Whitney equation. General solutions to the integrated dissolution model derived for noninteractive solutes as well as for solutes participating in ionization equilibrium are discussed. Parameters defining the integrated dissolution model are explained conceptually along with practical ways for their determinations. Conditions under which the model exhibits supersaturation features are elaborated. Simulated dissolution profiles using the integrated dissolution model for published experimental data exhibiting supersaturation features are illustrated.


Subject(s)
Models, Chemical , Solutions/pharmacokinetics , Diffusion , Kinetics , Solubility
9.
Coll Antropol ; 36(2): 375-80, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22856218

ABSTRACT

The clinical presentation of a subarachnoid block (SAB) is dependent upon the intrathecal spread of local anesthetic (LA). Intrathecal distribution depends on the chemical and physical characteristics of LA, puncture site, technique used, patient anatomical characteristics and hydrodynamic properties of cerebrospinal fluid. We tried to determine whether a combined glucose/LA solution can render a clinically significant difference in sensory block distribution and motor block intensity.This was a controlled, randomized and double blinded study. The surgical procedures were stripping of the great or small saphenous vein and extirpation of remaining varicose veins. The study included 110 patients distributed into two groups: Hyperbaric (7.5 mg levobupivacaine (1.5 ml 0.5% Chirocaine) + 50 microg Fentanyl (0.5 ml Fentanil) and 1 ml 10% glucose (Pliva)) vs. Hypobaric (7.5 mg levobupivacaine (1.5 ml 0.5% Chirocaine) + 50 microg Fentanyl (0.5 ml Fentanil) and 1 ml 0.9% NaCl (Pliva, Zagreb)) adding to a total volume of 3.5 ml per solution. Spinal puncture was at L3-L4 level. Spinal block distribution was assessed in five minute intervals and intensity of motor block was assessed according to the modified Bromage scale. Pain was assessed with the Visual Analogue Scale. A statistically significant difference in sensory block distribution, motor block intensity and recovery time was established between hyperbaric and hypobaric solutions. By increasing the specific density of anesthetic solution, a higher sensory block, with lesser variability, a diminished influence of Body Mass Index, decreased motor block intensity and faster recovery time may be achieved.


Subject(s)
Anesthesia, Spinal/methods , Fentanyl/pharmacokinetics , Varicose Veins/surgery , Adjuvants, Anesthesia/administration & dosage , Adjuvants, Anesthesia/adverse effects , Adjuvants, Anesthesia/pharmacokinetics , Adult , Anesthetics, Local/administration & dosage , Anesthetics, Local/adverse effects , Anesthetics, Local/pharmacokinetics , Bupivacaine/administration & dosage , Bupivacaine/adverse effects , Bupivacaine/analogs & derivatives , Bupivacaine/pharmacokinetics , Fentanyl/administration & dosage , Fentanyl/adverse effects , Humans , Levobupivacaine , Middle Aged , Pilot Projects , Solutions/pharmacokinetics , Subarachnoid Space
10.
Br J Anaesth ; 106(1): 51-6, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21051494

ABSTRACT

BACKGROUND: Fluid overload is a major complication during surgical hysteroscopy and transurethral resection of the prostate. We evaluated the role of temperature on absorption of the irrigation solution (IRRSOL) in endoscopic surgery when warm fluids are used to minimize hypothermia. METHODS: We measured the density and dynamic fluidity of five IRRSOLs (0.9% saline, Ringer's lactate, 1.5% glycine, 5% dextrose, and 2.5/0.54% sorbitol/mannitol) at three different temperatures (17°C, 27°C, and 37°C). Next, a hypothetical typical endoscopic resection surgery was defined as the reference: total IRRSOL absorption (750 ml), resection time (30 min), and IRRSOL temperature (17°C). On the basis of Poiseuille's law, we calculated new values for intravasation using the predetermined dynamic fluidity values at 27°C and 37°C to assess the influence of the IRRSOL temperature on intravascular absorption (under identical conditions) and then estimated the time to reach fluid overload at each temperature with both electrolyte and non-electrolyte IRRSOLs. RESULTS: Density and fluidity varied with temperature. In these specific conditions, when the temperature of the IRRSOL was increased from 17°C to 37°C, the mean absorption rate was predicted to increase about 54% and the theoretical 'safe' duration of surgery decreased by ∼65%, for both electrolyte and non-electrolyte IRRSOLs. The reduction in the 'safe' duration of surgery averaged 21.1 min for non-electrolyte IRRSOL (reduced from 60.0 to 38.9 min) and 35.2 min when electrolyte IRRSOLs were used (reduced from 100.0 to 64.8 min). CONCLUSIONS: Compared with cold fluids, isothermic IRRSOL may increase the risk of fluid overload because dynamic viscosity decreases at higher temperatures.


Subject(s)
Intraoperative Care/methods , Solutions/chemistry , Therapeutic Irrigation/methods , Humans , Hypothermia/prevention & control , Hysteroscopy/methods , Intraoperative Complications/prevention & control , Male , Rheology , Solutions/pharmacokinetics , Temperature , Transurethral Resection of Prostate/methods , Viscosity
11.
Arthroscopy ; 27(4): 532-41, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21186092

ABSTRACT

The lateral decubitus and beach-chair positions each offer unique benefits to the shoulder surgeon with respect to visualization, efficiency, and ease during arthroscopic shoulder procedures. The purpose of this article was to comprehensively review the reports and studies documenting independent and dependent complications related to patient positioning and anesthesia during arthroscopic shoulder surgery. The lateral decubitus position has been associated with the potential for peripheral neurapraxia, brachial plexopathy, direct nerve injury, and airway compromise. The beach-chair position has been associated with cervical neurapraxia, pneumothorax, and the potential for end-organ hypoperfusion injuries (when deliberate hypotension is used). Potentially concerning are hypotensive bradycardic events, which may be relatively common in association with the use of epinephrine-containing interscalene anesthetics in beach chair-positioned patients. Irrigant complications (fluid spread, ventricular tachycardia) are avoidable risks not unique to either specific position. Although minor transient anesthetic- and position-related complications (neurapraxia, hypotension) may occur in as many 10% to 30% of patients, major complications such as end-organ damage or permanent impairments are exceedingly rare. Regardless of position, complications are almost uniformly avoidable if surgeon and anesthetist exercise care and prudent attention to position and anesthetic choices. The purpose of this article is to review the potential for position- and anesthesia-related complications and acquaint the shoulder surgeon with the proposed pathophysiologic mechanisms that can lead to them.


Subject(s)
Arthroscopy/methods , Intraoperative Complications/etiology , Patient Positioning , Postoperative Complications/etiology , Posture , Shoulder Joint/surgery , Airway Obstruction/etiology , Airway Obstruction/physiopathology , Airway Obstruction/prevention & control , Anesthesia/adverse effects , Anesthesia/methods , Anesthetics/adverse effects , Brain Damage, Chronic/etiology , Brain Damage, Chronic/physiopathology , Brain Damage, Chronic/prevention & control , Cardiovascular Diseases/etiology , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/prevention & control , Evoked Potentials, Somatosensory , Humans , Hypotension, Controlled/adverse effects , Intraoperative Complications/physiopathology , Intraoperative Complications/prevention & control , Ischemia/etiology , Ischemia/physiopathology , Ischemia/prevention & control , Monitoring, Intraoperative , Peripheral Nerve Injuries , Peripheral Nervous System Diseases/etiology , Peripheral Nervous System Diseases/physiopathology , Peripheral Nervous System Diseases/prevention & control , Pneumothorax/etiology , Pneumothorax/physiopathology , Pneumothorax/prevention & control , Postoperative Complications/physiopathology , Postoperative Complications/prevention & control , Quadriplegia/etiology , Quadriplegia/physiopathology , Quadriplegia/prevention & control , Risk , Solutions/adverse effects , Solutions/pharmacokinetics , Spinal Cord/blood supply , Therapeutic Irrigation/adverse effects
12.
Int Dent J ; 61 Suppl 3: 41-5, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21762154

ABSTRACT

OBJECTIVES: To assess the retention of o-cymen-5-ol and zinc on reconstructed human gingival tissue delivered by topical applications of toothpaste formulated with 0.1%w/w o-cymen-5-ol and 0.6%w/w zinc chloride (ZnCl2). METHODS: EpiGingival tissues were treated topically for 2 minutes with either solutions or toothpaste slurries containing o-cymen-5-ol and ZnCl2. Tissues were rinsed with water between application and the effects of repeat dosing for up to 6 occasions were investigated. Tissues were blot dried, extracted and o-cymen-5-ol and zinc were measured by HPLC and atomic absorption spectroscopy, respectively. RESULTS: Retention of o-cymen-5-ol and zinc delivered from solutions to EpiGingival tissues showed a dose response to the concentration and to the number of applications. Significantly higher concentrations of zinc were delivered to EpiGingival tissues by toothpaste compared to equivalent doses delivered from solution. Equivalent doses of o-cymen-5-ol were delivered from toothpaste and solution. No cytotoxic effects on the EpiGingival tissues, measured by MTT viability, were detected following application of test toothpaste compared to a water control. CONCLUSIONS: Reconstructed human gingival tissue proved to be an effective model for the assessment of active retention from topically applied formulations. The test toothpaste was effective in delivering o-cymen-5-ol and zinc to oral soft tissue in vitro.


Subject(s)
Chlorides/pharmacokinetics , Gingiva/metabolism , Phenols/pharmacokinetics , Toothpastes/pharmacokinetics , Zinc Compounds/pharmacokinetics , Analysis of Variance , Chlorides/analysis , Chromatography, High Pressure Liquid , Humans , Phenols/analysis , Solutions/pharmacokinetics , Spectrophotometry, Atomic , Toothpastes/chemistry , Zinc Compounds/analysis
13.
Minerva Ginecol ; 62(1): 7-13, 13-6, 2010 Feb.
Article in English, Italian | MEDLINE | ID: mdl-20186111

ABSTRACT

AIM: Gynecological douches may contain various molecules that need to cover and be retained by cutaneous and mucosal cells if they are to act efficaciously in treating local conditions. The aim of this study was to investigate the possibility of directly visualising the ability of a commercial medical gynecological douche to bind to, and be retained by human vaginal cells. METHODS: The commercial gynecological douche under study was "Saugella Attiva douche", bought at local chemist. The vaginal epithelial cells were obtained from healthy, non-pregnant, regularly menstruating women aged 24-52 years. The cells were obtained from the mucosal surface of the mid-vaginal wall by means of gentle scraping with a sterile spatula. Ferric oxide particles and Escherichia coli were used as inorganic and organic markers in order to visualize the adherence of the transparent thin film of a gynecological douche to human vaginal cells by means of Nomarski interference contrast microscopy and scanning electron microscopy. RESULTS: Both markers made it possible to clearly visualize the binding and retention of the transparent thin layer of the douche also at the dilution 1:2 and 1:4. CONCLUSIONS: The fact that the douche can be locally retained is useful because its formulation contains thymol and eugenol, which are known to have antibacterial, antifungal and antioxidant effects but need a period of contact before they act fully.


Subject(s)
Anti-Infective Agents/pharmacokinetics , Antioxidants/pharmacokinetics , Feminine Hygiene Products , Solutions/pharmacokinetics , Vagina/drug effects , Vaginal Douching , Adult , Anti-Infective Agents/administration & dosage , Antioxidants/administration & dosage , Bacterial Adhesion/drug effects , Cells, Cultured/drug effects , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Epithelial Cells/ultrastructure , Escherichia coli/drug effects , Escherichia coli/physiology , Eugenol/administration & dosage , Eugenol/pharmacokinetics , Female , Humans , Microscopy, Electron, Scanning , Microscopy, Interference , Middle Aged , Shear Strength , Soaps/administration & dosage , Soaps/pharmacokinetics , Solutions/administration & dosage , Tensile Strength , Thymol/administration & dosage , Thymol/pharmacokinetics , Vagina/cytology , Young Adult
14.
Spectrochim Acta A Mol Biomol Spectrosc ; 71(5): 1688-94, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18692431

ABSTRACT

The electronic absorption spectra of: 2-, 3-, and 4-azidopyridines have been investigated in a wide variety of polar and non-polar solvents. According to Onsager model, the studied spectra indicate that the orientation polarization of solvent dipoles affects the electronic spectrum much stronger than the induction polarization of solvent dipoles. The effect of solvent dipole moment predominates that of solvent refractive index in determining the values of band maxima of an electronic spectrum. The spectra of azidopyridines differ basically from these of pyridine or mono-substituted pyridine. Results at hand indicate that the azide group perturbs the pyridine ring in the case of 3-azidopyridine much more than it does in the case of 2-azidopyridine. This result agrees with the predictions of the resonance theory. Although the equilibrium <==> azide tetrazole is well known, yet the observed spectra prove that such an equilibrium does not exist at the studied conditions. The spectra of the studied azidopyridines are characterized by the existence of overlapping transitions. Gaussian analysis is used to obtain nice, resolved spectra. All the observed bands correspond to pi-->pi* transitions, n-->pi* may be overlapped with the stronger pi-->pi* ones.


Subject(s)
Azides/chemistry , Pyridines/chemistry , Solutions/pharmacokinetics , Solvents/pharmacokinetics , Absorption , Azides/pharmacokinetics , Electrons , Energy Transfer/physiology , Models, Biological , Pyridines/pharmacokinetics , Solutions/chemistry , Solvents/chemistry , Spectrophotometry, Infrared , Spectrum Analysis
15.
J Pharm Sci ; 108(9): 3003-3010, 2019 09.
Article in English | MEDLINE | ID: mdl-31054887

ABSTRACT

Despite a number of studies showed that hair follicular pathway contributed significantly to transdermal delivery, there have been limited studies on the diffusion properties of chemicals in sebum. Here, the diffusion property of 17 chemical compounds across artificial sebum has been measured using diffusion cell. The diffusion flux showed 2 types of distinctive behaviors: that reached steady state and that did not. Mathematical models have been developed to fit the experimental data and derive the sebum diffusion and partition coefficients. The models considered the uneven thickness of the sebum film and the additional resistance of the unstirred aqueous boundary layer and the supporting filter. The derived sebum-water partition coefficients agreed well with the experimental data measured previously using equilibrium depletion method. The obtained diffusion coefficients in artificial sebum only depended on the molecular size. Change in pH for ionic chemicals did not affect the diffusion coefficients but influenced their diffusion flux because of the change of sebum-water partition coefficients. Generally, the measured diffusion coefficients of chemicals in artificial sebum are about one order of magnitude higher than those in the stratum corneum lipids, suggesting the hair follicle might have a non-negligible contribution to the overall permeation.


Subject(s)
Biomimetic Materials/metabolism , Sebum/metabolism , Solutions/pharmacokinetics , Administration, Cutaneous , Biomimetic Materials/chemistry , Diffusion , Hydrogen-Ion Concentration , Permeability , Sebum/chemistry , Skin Absorption , Water/chemistry
16.
Gen Hosp Psychiatry ; 30(4): 367-71, 2008.
Article in English | MEDLINE | ID: mdl-18585542

ABSTRACT

OBJECTIVE: Efficacy and tolerability of risperidone oral solution (RIS-OS) and olanzapine orally disintegrating tablet (OLZ-ODT) were compared for the treatment of acute psychotic agitation. METHOD: During a 2-month period, patients scoring > or =15 on the Excited Component for Positive and Negative Syndrome Scale (PANSS-EC) were assigned to treatment with OLZ-ODT (n=34) or RIS-OS (n=53) on psychiatric emergency situations, and assessed every 15 min. RESULTS: Two (OLZ-ODT and RIS-OS) by five (0-, 15-, 30-, 45- and 60-min time points) repeated-measures analysis of variance revealed only a significant main effect of time course on PANSS-EC (F=82.2, P<.0001). No differences in the number of patients receiving additional injection due to worsening were found (OLZ-ODT, 11.8%; RIS-OS, 9.4%). No differences in rate of extrapyramidal symptoms and patient satisfaction with assigned treatment were found. However, patients in the OLZ-ODT group recovered significantly more from tachycardia than those in the RIS-OS group (t=2.17, P=.03). CONCLUSION: OLZ-ODT and RIS-OS treatments yielded similar improvements in acutely agitated patients who accepted oral medication. However, on one physiological parameter (i.e., tachycardia) OLZ-ODT might be superior to RIS-OS. Physiological indicators may also be useful for measuring levels of agitation.


Subject(s)
Antipsychotic Agents/administration & dosage , Benzodiazepines/administration & dosage , Benzodiazepines/pharmacokinetics , Psychotic Disorders/drug therapy , Risperidone/administration & dosage , Acute Disease , Administration, Oral , Adult , Antipsychotic Agents/pharmacokinetics , Attitude to Health , Blood Pressure/drug effects , Female , Heart Rate/drug effects , Humans , Male , Olanzapine , Patient Compliance , Patient Satisfaction , Psychiatric Status Rating Scales/statistics & numerical data , Psychomotor Agitation/diagnosis , Psychomotor Agitation/drug therapy , Psychomotor Agitation/metabolism , Psychotic Disorders/diagnosis , Psychotic Disorders/metabolism , Risperidone/pharmacokinetics , Solutions/administration & dosage , Solutions/pharmacokinetics , Tablets/administration & dosage , Tablets/pharmacokinetics , Tachycardia/diagnosis , Tachycardia/drug therapy , Treatment Outcome
17.
J Toxicol Environ Health A ; 71(8): 486-94, 2008.
Article in English | MEDLINE | ID: mdl-18338283

ABSTRACT

Water plays a key role in enhancing the permeability of human skin to many substances. To further understand its ability to potentially increase the bioavailability of soil contaminants, artificial sweat was applied to excised pig skin prior to dosing with munition-contaminated soils. Skin was mounted in chambers to allow simultaneous measurement of evaporation and penetration and to control air flow, which changed the dwell time of skin surface water within a l-h period post application of test materials. Additional variables included type of compound, aging of spiked soil samples, and carbon content of soil. To this end, the evaporation and skin penetration of C-14 labeled hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), 2,6-dinitrotoluene (26DNT), and 2,4,6-trinitrotoluene (TNT) were determined from two soil types, Yolo, having 1.2% carbon, and Tinker, having 9.5% carbon. RDX soil samples aged 27 mo and 62 mo were compared to freshly spiked soils samples. Similarly, 26DNT samples aged 35-36 mo and TNT samples aged 18 mo were compared to freshly spiked samples. Approximately 10 microg/cm(2) of radiolabeled compound was applied in 10 mg/cm(2) of soil. Radiolabel recovered from the dermis and tissue culture media (receptor fluid) was summed to determine percent absorption from the soils. Radiolabel recovered from vapor traps determined evaporation. Mean skin absorption of all compounds was higher for low-carbon soil, regardless of soil age and skin surface water as affected by air flow conditions. For 26DNT, a simultaneous increase in evaporation and penetration with conditions that favored enhanced soil hydration of freshly prepared samples was consistent with a mechanism that involved water displacement of 26DNT from its binding sites. A mean penetration of 17.5 +/- 3.6% was observed for 26DNT in low-carbon soil, which approached the value previously reported for acetone vehicle (24 +/- 6%). 26DNT penetration was reduced to 0.35% under dryer conditions and to 0.08% when no sweat was applied. When soil hydration conditions were not varied from cell to cell, air flow that favored a longer water dwell time increased penetration, but not evaporation, consistent with a mechanism of enhanced skin permeability from a higher hydration state of the stratum corneum. Profiles of 26DNT penetration versus air flow conditions were exponential for freshly prepared soil samples, suggesting strong and weak binding sites; corresponding profiles of 26DNT penetration from aged samples were linear, suggesting a conversion of weak to strong binding sites. Absorption and evaporation was less than 5% for TNT and less than 1% for RDX, regardless of soil type and age. Fresh preparations of RDX in Tinker soil and aged samples of TNT in Yolo soil showed a significant decrease in skin absorption with loss of surface moisture. The penetration rate of radiolabel into the receptor fluid was highest during the 1-2 h interval after dosing with 26DNT or TNT. High-performance liquid chromatography (HPLC) analysis of 26DNT in receptor fluid at maximum flux indicated no metabolism or breakdown. For TNT, however, extensive conversion to monoamino derivatives and other metabolites was observed. Relatively little radioactivity was found in the dermis after 26DNT and TNT applications, and dermal extracts were therefore not analyzed by HPLC. RDX was not sufficiently absorbed from soils to allow HPLC analysis. This study has practical significance, as the use of water for dust control at remediation sites may have the unintended effect of increasing volatilization and subsequent absorption of soil contaminants. Soil in contact with sweaty skin may give the same result. Skin absorption of 26DNT from soil was over 50-fold higher than the value for dryer skin and over 200-fold higher than the value obtained when there was no sweat application. While the hydration effect was less dramatic for RDX and TNT, soil contaminants more closely matching the physical properties of 26DNT may be similarly affected by hydration.


Subject(s)
Explosive Agents/pharmacokinetics , Skin Absorption/drug effects , Soil Pollutants/pharmacokinetics , Sweat , Trinitrotoluene/pharmacokinetics , Animals , Biological Availability , Carbon Isotopes/pharmacokinetics , Explosive Agents/chemistry , Female , Humans , Radioactive Tracers , Soil , Soil Pollutants/chemistry , Solutions/pharmacokinetics , Sus scrofa , Sweating , Time Factors , Trinitrotoluene/chemistry , Volatilization
18.
Arthroscopy ; 24(8): 966-8, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18657748

ABSTRACT

The case of intra- and retroperitoneal irrigation solution after hip arthroscopy of a 15-year-old girl is presented. She underwent hip arthroscopy for intra-articular adhesiolysis after previous surgical dislocation of the hip for the treatment of femoroacetabular impingement. Arthroscopy was performed in the lateral decubitus position without traction to debride the peripheral joint compartment. The irrigation pressure was set at 40 mm Hg. There were no intraoperative complications. By the end of surgery, the anesthesiologist reported a drop in the patient's body temperature from 36.3 degrees to 34.5 degrees C. Postoperatively, she complained about abdominal swelling and discomfort. Abdominal sonography revealed approximately 2 to 3 L of intra- and retroperitoneal liquid, which was considered to be irrigation fluid. The irrigation fluid was absorbed within 16 hours without further treatment. The only possible way the irrigation fluid could have flown was a retroperitoneal course along the iliopsoas muscle and the iliac vessels with intraperitoneal perforation along their course. We observed at arthroscopies that irrigation pressure incidentally can rise to 140 mm Hg when leaking of fluid through the portals occurs. Intra-abdominal fluid is a potentially devastating complication. A sudden drop of body temperature has to raise suspicion for intra-abdominal leaking of irrigation fluid.


Subject(s)
Arthroscopy , Hip Joint/surgery , Peritoneum/metabolism , Retroperitoneal Space , Solutions/pharmacokinetics , Therapeutic Irrigation/adverse effects , Absorption , Adolescent , Female , Humans , Peritoneum/diagnostic imaging , Retroperitoneal Space/diagnostic imaging , Time Factors , Ultrasonography
19.
Drugs R D ; 18(2): 149-159, 2018 06.
Article in English | MEDLINE | ID: mdl-29856004

ABSTRACT

OBJECTIVE: The aim of this study was to summarise the pharmacokinetic findings from eight phase I studies in healthy volunteers given oral AZD5069, a selective small-molecule CXCR2 antagonist. METHODS: 240 healthy volunteers across eight phase I studies received single (0.1-200 mg) or multiple once- or twice-daily (10-120 mg) oral AZD5069 as solution, suspension, capsules or tablets. Pharmacokinetics were evaluated using non-compartmental analysis methods. RESULTS: AZD5069 was rapidly absorbed (time to maximum concentration ~ 2 h) under fasting conditions. A high-fat, high-calorie meal delayed and reduced the peak plasma AZD5069 concentration (Cmax) by 50%, but total exposure (AUC) was unchanged (fed:fasting geometric mean ratio 90% confidence interval within 0.80-1.25). The plasma concentration of AZD5069 declined with an initial half-life of 4 h and terminal half-life of 11 h. Steady-state plasma concentrations were achieved within 2-3 days and accumulation was ~ 1.1-fold with twice-daily dosing. Systemic exposure was approximately proportional to dose. Intra- and inter-subject variability in AUC was 3-11 and 29-64%, respectively. Less than 5% of the AZD5069 dose was excreted as parent drug in the urine. Elderly subjects had 39% higher AZD5069 AUC and 21% higher Cmax than younger adults. Japanese subjects had similar or slightly higher exposure to AZD5069 than Caucasian subjects. Co-administration with ketoconazole resulted in 2.1-fold higher AUC and 1.6-fold higher Cmax. All formulations had similar bioavailability. CONCLUSIONS: AZD5069 demonstrated predictive linear pharmacokinetics with low intra- and moderate inter-subject variability and no major influences from ethnicity, age, food or formulation. Half-life data indicated suitability for twice-daily dosing. CLINICALTRIALS. GOV IDENTIFIERS: NCT00953888, NCT01051505, NCT01083238, NCT01100047, NCT01332903, NCT01480739, NCT01735240, NCT01989520.


Subject(s)
Pyrimidines/pharmacokinetics , Sulfonamides/pharmacokinetics , Adolescent , Adult , Age Factors , Aged , Biological Availability , Capsules/pharmacokinetics , Clinical Trials, Phase I as Topic , Dose-Response Relationship, Drug , Drug Interactions , Female , Food-Drug Interactions , Healthy Volunteers , Humans , Ketoconazole/pharmacology , Male , Middle Aged , Pyrimidines/blood , Pyrimidines/urine , Solutions/pharmacokinetics , Sulfonamides/blood , Sulfonamides/urine , Suspensions/pharmacokinetics , Tablets/pharmacokinetics , Young Adult
20.
J Clin Invest ; 91(4): 1590-7, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8473502

ABSTRACT

An understanding of the fluid and electrolyte transport properties of any epithelium requires knowledge of the direction, rate, and regulation of fluid transport and the composition of the fluid. Although human airway epithelial likely play a key role in controlling the quantity and composition of the respiratory tract fluid, evidence for such a role is not available. To obtain such knowledge, we measured fluid and electrolyte transport by cultured human nasal epithelia. Under basal conditions we found that epithelia absorbed Na+ and fluid; both processes were inhibited by addition of amiloride to the mucosal surface. These data suggest that active Na+ absorption is responsible for fluid absorption. Interestingly, Na+ absorption was not accompanied by the net absorption of Cl-; some other anion accompanied Na+. The combination of cAMP agonists and mucosal amiloride stimulated the secretion of NaCl-rich fluid. But surprisingly, the response to cAMP agonists in the absence of amiloride showed substantial intersubject variability: cAMP stimulated fluid secretion across some epithelia, for others, cAMP stimulated fluid absorption. The explanation for the differences in response is uncertain, but we speculate that the magnitude of apical membrane Na+ conductance may modulate the direction of fluid transport in response to cAMP. We also found that airway epithelial secrete H+ and absorb K+ under basal conditions; both processes were inhibited by cAMP agonists. Because the H+/K(+)-ATPase inhibitor, SCH 28080, inhibited K+ absorption, an apical membrane H+/K(+)-ATPase may be at least partly responsible for K+ and H+ transport. However, H+/K+ exchange could not entirely account for the luminal acidification. The finding that cAMP agonists inhibited luminal acidification may be explained by the recent finding that cAMP increases apical HCO3- conductance. These results provide new insights into how the intact airway epithelium may modify the composition of the respiratory tract fluid.


Subject(s)
Body Fluids/metabolism , Electrolytes/metabolism , Nasal Mucosa/cytology , Amiloride/pharmacology , Biological Transport , Cells, Cultured , Chlorides/metabolism , Cystic Fibrosis/metabolism , Epithelial Cells , Humans , Ion Transport , Nasal Mucosa/metabolism , Potassium/metabolism , Sodium/metabolism , Solutions/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL